Mirae Asset Global ETFs Holdings
RCUS icon

Mirae Asset Global ETFs Holdings’s Arcus Biosciences RCUS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
49,526
+2,015
+4% +$49.8K ﹤0.01% 1399
2026
Q1 		$1.02M Buy
47,511
+5,556
+13% +$120K ﹤0.01% 1517
2025
Q4 		$997K Buy
41,955
+6,590
+19% +$134K ﹤0.01% 1519
2025
Q3 		$480K Sell
35,365
-7,477
-17% -$77.7K ﹤0.01% 1881
2025
Q2 		$348K Buy
42,842
+5,270
+14% +$45K ﹤0.01% 1998
2025
Q1 		$297K Buy
37,572
+3,565
+10% +$41.3K ﹤0.01% 2116
2024
Q4 		$506K Buy
34,007
+833
+3% +$13.6K ﹤0.01% 1912
2024
Q3 		$508K Buy
33,174
+1,909
+6% +$30.1K ﹤0.01% 1901
2024
Q2 		$476K Buy
+31,265
New +$505K ﹤0.01% 1848

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RCUS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Arcus Biosciences (RCUS) stake by 4.2% in Q2 2026, buying an estimated $49.8K and bringing the position to 49,526 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1399.

Mirae Asset Global ETFs Holdings first reported a position in RCUS in Q2 2024 and has held it in 9 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 49,526 shares of Arcus Biosciences worth $1.53M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 2,015 Arcus Biosciences shares in Q2 2026, an estimated $49.8K.
  • Arcus Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1399 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Arcus Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.